Oxular

Developer of drug delivery platform and therapeutics for ophthalmology

placeOxford, England, United Kingdom calendar_todayFounded 2014 groups6 employees language oxular.com

Registered entities

Innovation

7 patent families (5 granted) — focus: Human necessities; filing pace slowing. Cited 576 times.

YearFilings
20161
20173
20183
20194
20206
20215
20224
20233
20242
20251
20261

Investor mix

22 investors on record; lead investors include Imperial Innovations, Forbion.

Investor typeCountShare
Venture capital523%
Accelerator & incubator15%
Bank & private debt15%
Other / undisclosed1568%
Coming soon